Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(510)
•••
Comment by 2b7f6fabon Feb 22, 2018 11:38am
116 Views
Post# 27602142

RE:RE:RE:Can everybody stop buying, please?

RE:RE:RE:Can everybody stop buying, please?I think you're being too hard on TLT mgmt. It wasn't mgmt fault for the delay in approval and the 6 months delay between patient 4 and 5 was on the hospital and doctors. Even then the doctors may have used that time to find patients without the uutc and dialing in the treatment process. Imagine if patients 5~9 come in cancer free at 6 months. Or even just a couple of them are cancer free. There's still ~30 million warrants and 10 million options that could be exercised on good news, bringing in enough money to fund ph2. gltal
Smallcap84 wrote: Thats right riverrow..and those that bought in the .50's feel even stronger about it..:-)...If TLT even comes close to getting their &hit together with respect to a viable treatment (which imo they already have) then .25 right now will be viewed as chump change in the not to distant future...


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities